Inogen Inc Total Liabilities

Latest as of March 2026: $103.02 Million USD

Inogen Inc total liabilities. Based on the latest financial reports, Inogen Inc (INGN) has total liabilities worth $103.02 Million USD as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Inogen Inc asset resilience ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Inogen Inc (2011–2025)

Total liabilities of Inogen Inc from 2011 to 2025. This chart illustrates how Inogen Inc's total liabilities have evolved over time, based on quarterly financial data.

Inogen Inc Competitors by Total Liabilities

The table below lists competitors of Inogen Inc ranked by their total liabilities.

Company Country Total Liabilities
Tunas Baru Lampung Tbk
JK:TBLA
Indonesia Rp20.62 Trillion
Wismilak Inti Makmur Tbk
JK:WIIM
Indonesia Rp1.29 Trillion
Jw Holdings
KO:096760
Korea ₩662.18 Billion
United Paper Public Company Limited
BK:UTP
Thailand ฿467.78 Million
Twelve Seas Investment Co II
NASDAQ:TWLV
USA $7.07 Million
Brightcom Group Limited
NSE:BCG
India Rs-105.71 Billion
Stereotaxis Inc
NYSE MKT:STXS
USA $34.05 Million
Daesang Holdings Co Ltd
KO:084690
Korea ₩2.74 Trillion

Liability Composition Analysis (2011–2025)

This chart breaks down Inogen Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Inogen Inc (INGN) total assets.

Liquidity & Leverage Metrics

Inogen Inc Total Liabilities Ratios Explained

Inogen Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric Value Description
Current Ratio 3.10 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.56 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.36 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Inogen Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Inogen Inc (2011–2025)

The table below shows the annual total liabilities of Inogen Inc from 2011 to 2025.

Year Total Liabilities Change
2025-12-31 $106.39 Million -13.02%
2024-12-31 $122.33 Million +0.78%
2023-12-31 $121.38 Million +12.77%
2022-12-31 $107.64 Million -9.77%
2021-12-31 $119.29 Million +6.29%
2020-12-31 $112.23 Million +9.26%
2019-12-31 $102.72 Million +56.88%
2018-12-31 $65.47 Million +36.32%
2017-12-31 $48.03 Million +50.28%
2016-12-31 $31.96 Million +17.09%
2015-12-31 $27.30 Million +24.44%
2014-12-31 $21.93 Million -15.95%
2013-12-31 $26.10 Million +37.28%
2012-12-31 $19.01 Million +14.70%
2011-12-31 $16.57 Million --

About Inogen Inc

NASDAQ:INGN USA Medical Devices
Market Cap
$190.06 Million
Market Cap Rank
#16749 Global
#3991 in USA
Share Price
$7.02
Change (1 day)
+2.18%
52-Week Range
$5.09 - $7.39
All Time High
$282.92
About

Inogen, Inc., a medical technology company, develops, manufactures, and markets respiratory health products in the United States and internationally. The company offers portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. It provides Inogen One and Inogen Rove, an ambulatory solution for long-term oxygen the… Read more